Alopecia areata
- Limited disease → intralesional/topical corticosteroid
- Extensive disease may use oral JAK inhibitor
- Baricitinib/ritlecitinib are key approved options
- Spontaneous regrowth can occur
- Screen treatment risk for infection/labs with systemic JAK therapy
- Support cosmetic/psychological impact
Use at a glance
- Limited disease → intralesional/topical corticosteroid
Practical pearls
- Extensive disease may use oral JAK inhibitor
Other practical pearls
- Baricitinib/ritlecitinib are key approved options
- Spontaneous regrowth can occur
Treatment options
- Screen treatment risk for infection/labs with systemic JAK therapy
- Support cosmetic/psychological impact
Self-check
- What is recommended for Limited disease in Alopecia areata?
intralesional/topical.
Drugs used for this (2)
All clinical uses · Open the interactive console ↗
